Guangzhou Sinogen pharmaceutical was selected as the bellwether of enterprises to be listed in Guangzhou in 2022.

On December 9, 2022, the selection results of the "bellwether" of the enterprises to be listed in Guangzhou were announced, and Sinogen Pharmaceutical was successfully selected into the list of "Top 10 bellwether enterprises with the most capital attention in Guangzhou in 2022".

This selection, through enterprise application, data verification, quantitative preliminary screening, enterprise visit, review panel review and other links, finally selected the "Top 10 bellwether enterprises with the most capital attention in Guangzhou in 2022", "Top 10 bellwether enterprises with most growing in Guangzhou in 2022" and other lists.
Sinogen Pharmaceutical, which has developed the first-in-class tumor-targeting drug based on amino acid metabolism, its core oncolytic bacteria product SGN1® (SalMet-Vec ®) is carrying out Phase I/IIa registered clinical trials of intravenous and intratumoral administration for broad-spectrum solid tumors in the United States and Taiwan, China. This listing is an affirmation of the development achievements of Sinogen Pharmaceutical, and will also encourage the company to accelerate its progress towards the dual goals of product listing and enterprise listing.

Introduction to the selection of "bellwether" of enterprises to be listed in Guangzhou in 2022

In order to further explore and cultivate a number of outstanding enterprises to be listed with the attribute of "bellwether", expand the financing channels for enterprises to be listed, and improve the capital market service system, under the guidance and support of the Guangzhou Local Financial Supervision and Administration, from June to December 2022, the Guangzhou Financial Development Service Center, in conjunction with the Guangzhou Branch of the Industrial and Commercial Bank of China and the Guangdong Equity Exchange Center, China Merchants Securities co-organized the selection of "bellwether" of enterprises to be listed in Guangzhou in 2022. In this selection activity, financial experts from Guangzhou Capital Market Library, well-known private equity investment institutions, securities companies, industry associations and other institutions were invited to serve as the judges, and the selected enterprises were classified and selected in terms of scientific and technological innovation, capital attention, enterprise growth and other dimensions.